Sharps Compliance (SMED) Misses Q3 EPS by 7c

Sharps Compliance (NASDAQ: SMED) reported Q3 EPS of ($0.07), $0.07 worse than the analyst estimate of $0.00. Revenue for the quarter came in at $8.7 million versus the consensus estimate of $7.67 million.

For earnings history and earnings-related data on Sharps Compliance (SMED) click here.

You May Also Be Interested In

• Is Treasury selloff a major issue for stock market bulls?
• Jasper Therapeutics (JSPR) Tops Q2 EPS by 18c
• Traws Pharma (TRAW) Tops Q2 EPS by 27c